{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P78545",
      "entity_text" : "ERT",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P61073",
      "entity_text" : "CXCR4",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Since most of the patients in whom CXCR4 directed ERT might become an option (G3 NET) receive hematotoxic standard chemotherapeutic regimens (platinum / etoposide) as first-line treatment, identification of sufficient receptor expression early in the course of treatment is essential in order not to harm successful stem cell mobilization.",
  "reading_complete" : "2020-08-02T10:35:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:29:42Z",
  "trigger" : "directed",
  "evidence" : [ "CXCR4-directed ERT" ],
  "pmc_id" : "5436508",
  "score" : 0
}